Atlas Trials

A Study In Healthy People Of Multiple Doses Of UK-396,082 Given By Mouth, To Investigate The Safety, Toleration And Time Course Of Blood Concentration Of UK-396,082 And Its Effects.

Clinical trial NCT01091532 · COMPLETED

Trial details

NCT number
NCT01091532
Sponsor
Pfizer
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Phase 1Multiple DoseSafetyTolerationPharmacokinetic
Start date
2010-03-01
Primary completion
2010-07-01
Enrollment
48

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.